Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Feb 2015 07:00 AM
SAREUM HOLDINGS PLC : Research & Co-Development...
25 Feb 2015 07:00 AM
SAREUM HOLDINGS PLC : Half-yearly report
20 Jan 2015 07:00 AM
RNS
Further US Patent Grant for Kinase Inhibitors
17 Dec 2014 12:26 PM
SAREUM HOLDINGS PLC : Result of AGM
15 Dec 2014 05:00 PM
SAREUM HOLDINGS PLC : CHK1 Update
04 Dec 2014 07:00 AM
SAREUM HOLDINGS PLC : Chinese Patent Grant for ...
26 Nov 2014 10:30 AM
SAREUM HOLDINGS PLC : Issue of Options
10 Nov 2014 07:00 AM
SAREUM HOLDINGS PLC : First Patent Grant for Sa...
10 Nov 2014 07:00 AM
SAREUM HOLDINGS PLC : Notice of AGM
14 Oct 2014 07:00 AM
SAREUM HOLDINGS PLC : Final Results
13 Oct 2014 08:20 AM
RNS
Holding(s) in Company
01 Oct 2014 07:00 AM
RNS
Promising Step in Psoriasis Drug Development
22 Sep 2014 07:00 AM
RNS
CHK1 Patent Update
09 Sep 2014 10:54 AM
SAREUM HOLDINGS PLC : Holding(s) in Company
10 Jul 2014 03:30 PM
SAREUM HOLDINGS PLC : Holding(s) in Company
02 Jul 2014 07:00 AM
RNS
Japanese Patent Grant for Kinase Inhibitors
30 Jun 2014 02:15 PM
RNS
Total Voting Rights
26 Jun 2014 07:00 AM
RNS
Preclinical Proof of Concept in TYK2 Programme
13 Jun 2014 07:00 AM
SAREUM HOLDINGS PLC : Issue of Equity
26 Feb 2014 07:01 AM
SAREUM HOLDINGS PLC : Research Update & Co-Deve...
26 Feb 2014 07:00 AM
SAREUM HOLDINGS PLC : Half-yearly report
22 Jan 2014 07:00 AM
RNS
CHK1 Patent Update
19 Dec 2013 07:00 AM
Issue of Options
11 Dec 2013 11:38 AM
Result of AGM
02 Dec 2013 07:00 AM
Co-Development Agreement
29 Nov 2013 10:11 AM
Total Voting Rights
13 Nov 2013 09:55 AM
Correction: Notice of AGM
13 Nov 2013 07:00 AM
Notice of AGM
01 Nov 2013 07:00 AM
Placing to raise £1.67 million
25 Oct 2013 07:00 AM
RNS
Sareum to Present at London Investor Show
10 Oct 2013 07:01 AM
SAREUM HOLDINGS PLC : Final Results
24 Sep 2013 07:00 AM
Co-development Agreement to Advance CHK1 Programme
12 Aug 2013 07:00 AM
SAREUM HOLDINGS PLC : Trading Statement
15 Jul 2013 07:00 AM
SAREUM HOLDINGS PLC : Selection for Preclinical...
10 May 2013 12:00 PM
SAREUM HOLDINGS PLC : Total voting rights
24 Apr 2013 07:01 AM
Statement re Grant Award
22 Apr 2013 07:02 AM
Co-devlopment Agreement
25 Mar 2013 07:00 AM
SAREUM HOLDINGS PLC : Issue of Equity
19 Mar 2013 07:00 AM
SAREUM HOLDINGS PLC : Adviser Change of Name
18 Feb 2013 07:01 AM
SAREUM HOLDINGS PLC : Research Update
18 Feb 2013 07:00 AM
Half-yearly report
11 Feb 2013 04:40 PM
SAREUM HOLDINGS PLC : Director Declaration
07 Feb 2013 07:00 AM
Statement re Patent Grant
04 Feb 2013 07:00 AM
SAREUM HOLDINGS PLC : Notice of Results
31 Dec 2012 10:42 AM
SAREUM HOLDINGS PLC : Total voting rights
12 Dec 2012 11:57 AM
SAREUM HOLDINGS PLC : Result of AGM
12 Dec 2012 07:02 AM
SAREUM HOLDINGS PLC : AGM Statement
05 Dec 2012 11:31 AM
SAREUM HOLDINGS PLC : Issue of Equity
14 Nov 2012 09:51 AM
SAREUM HOLDINGS PLC : Notice of AGM
13 Nov 2012 03:26 PM
CORRECTION: Availability of Report and Accounts

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings